Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Boston Scientific finalizes $1.75B acquisition | Best of KLAS 2022 | Cardiologist accused of sexual assault
Thursday, February 17, 2022
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

Boston Scientific finalizes acquisition of Baylis Medical with $1.75B payment

The deal, first announced in October 2021, expands Boston Scientific’s structural heart disease and electrophysiology portfolios by a significant margin. 

READ MORE >
Money dollar investments
Share on Twitter Share on Facebook Share on Linkedin

Boston Scientific finalizes acquisition of Baylis Medical with $1.75B payment

Share on Twitter Share on Facebook Share on Linkedin
Money dollar investments
The deal, first announced in October 2021, expands Boston Scientific’s structural heart disease and electrophysiology portfolios by a significant margin. 
READ MORE >

Best of KLAS 2022: The top cardiovascular information systems and hemodynamic solutions

KLAS Research released its 2022 Best in KLAS report, which includes cardiovascular information systems and hemodynamic systems. 

READ MORE >
Part of the echo reporting functionality from Fujifilm Synapse Cardiovascular. This CVIS was ranked Best in KLAS in 2022 based on user interviews.
Share on Twitter Share on Facebook Share on Linkedin

Best of KLAS 2022: The top cardiovascular information systems and hemodynamic solutions

Share on Twitter Share on Facebook Share on Linkedin
Part of the echo reporting functionality from Fujifilm Synapse Cardiovascular. This CVIS was ranked Best in KLAS in 2022 based on user interviews.
KLAS Research released its 2022 Best in KLAS report, which includes cardiovascular information systems and hemodynamic systems. 
READ MORE >

Cardiologist leaves practice after sexual assault accusation

The 65-year-old cardiologist, based out of Calgary, has been charged with one count of sexual assault.

READ MORE >
OhCanada
Share on Twitter Share on Facebook Share on Linkedin

Cardiologist leaves practice after sexual assault accusation

Share on Twitter Share on Facebook Share on Linkedin
OhCanada
The 65-year-old cardiologist, based out of Calgary, has been charged with one count of sexual assault.
READ MORE >

Ticagrelor alone after DAPT lowers bleeding risk among heart attack patients undergoing PCI

Researchers examined data from the TWILIGHT study to track how different treatment strategies can impact 12-month PCI outcomes. 

READ MORE >
older male patient and doctor
Share on Twitter Share on Facebook Share on Linkedin

Ticagrelor alone after DAPT lowers bleeding risk among heart attack patients undergoing PCI

Share on Twitter Share on Facebook Share on Linkedin
older male patient and doctor
Researchers examined data from the TWILIGHT study to track how different treatment strategies can impact 12-month PCI outcomes. 
READ MORE >

Featured Articles

Heart Team consultations lead to better patient outcomes, fewer unexpected hospitalizations

When a heart team's recommendations were followed, for example, the authors noted a “significant reduction” in cardiac mortality.

READ MORE >
Group of doctors.jpg
Share on Twitter Share on Facebook Share on Linkedin

Heart Team consultations lead to better patient outcomes, fewer unexpected hospitalizations

Share on Twitter Share on Facebook Share on Linkedin
Group of doctors.jpg
When a heart team's recommendations were followed, for example, the authors noted a “significant reduction” in cardiac mortality.
READ MORE >

Cardiac MRI sheds new light on vaccine-related myocarditis

Vaccine-associated myocarditis shows an injury pattern on cardiac MRI similar to other causes of myocarditis, but abnormalities are less severe. 

READ MORE >
COVID-19 vaccine associated myocarditis on short-axis 1.5T MRI images of a 19-year-old man who presented with chest pain three days following the second dose of an mRNA COVID-19 vaccine.
Share on Twitter Share on Facebook Share on Linkedin

Cardiac MRI sheds new light on vaccine-related myocarditis

Share on Twitter Share on Facebook Share on Linkedin
COVID-19 vaccine associated myocarditis on short-axis 1.5T MRI images of a 19-year-old man who presented with chest pain three days following the second dose of an mRNA COVID-19 vaccine.
Vaccine-associated myocarditis shows an injury pattern on cardiac MRI similar to other causes of myocarditis, but abnormalities are less severe. 
READ MORE >

Senate confirms cardiologist Robert Califf as next FDA commissioner

Robert Califf, MD, previously led the FDA under President Barack Obama. 

READ MORE >
 U.S. Senate has confirmed cardiologist Robert Califf as next FDA commissioner. 
Share on Twitter Share on Facebook Share on Linkedin

Senate confirms cardiologist Robert Califf as next FDA commissioner

Share on Twitter Share on Facebook Share on Linkedin
 U.S. Senate has confirmed cardiologist Robert Califf as next FDA commissioner. 
Robert Califf, MD, previously led the FDA under President Barack Obama. 
READ MORE >

Empagliflozin helps heart failure patients stay out of the hospital

The study's authors focused on data from the previously completed EMPEROR-Reduced and EMPERIOR-Preserved trials.

READ MORE >
Elderly patient doctor. Despite an expanded indication from the FDA and lower prices, patient access to these cholesterol-lowering medications remains a significant issue.
Share on Twitter Share on Facebook Share on Linkedin

Empagliflozin helps heart failure patients stay out of the hospital

Share on Twitter Share on Facebook Share on Linkedin
Elderly patient doctor. Despite an expanded indication from the FDA and lower prices, patient access to these cholesterol-lowering medications remains a significant issue.
The study's authors focused on data from the previously completed EMPEROR-Reduced and EMPERIOR-Preserved trials.
READ MORE >

In Other News

Health-tech companies back new legislation introduced to modernize ‘outdated’ health privacy laws

Teladoc Health, IBM, Epic and others all support the bipartisan Health Data Use and Privacy Commission Act.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Health-tech companies back new legislation introduced to modernize ‘outdated’ health privacy laws

Share on Twitter Share on Facebook Share on Linkedin
Teladoc Health, IBM, Epic and others all support the bipartisan Health Data Use and Privacy Commission Act.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Safety concerns lead to new recall | FDA approves surgical device | Parents in jail after obese son's death | A fraud warning
AI making an impact behind the scenes | New EARLY TAVR data | Americans keep poisoning themselves with semaglutide
Week in Review: TAVR vs. SAVR | FDA clears AI tech | Payment model confusion | Private equity & cardiology | Injuries after PCI
Heart surgery kits recalled | Sex-specific outcomes after TAVR & SAVR | A new risk calculator | FDA clears tricuspid valve
Thousands of heart surgery kits recalled | TAVR for AR linked to 'encouraging' data | Carotid IVL | Progress for new HCM drug
AI company founded by cardiologist makes big splash | Getting clinicians on the same page | Kidney injuries after PCI
Sweeping TAVR changes on the way | Pushing back against AI-powered prior authorization | FDA highlights recall after injuries

Pagination

    • Current page 1
    • Page 2
    • Page 3
    • Page 4
    • Page 5
    • Page 6
    • Page 7
    • Page 8
    • Page 9 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme